Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
9 p, 559.7 KB Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients / Sesé, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Somoza, Rosa (VHIR Vall d'Hebron Institut de Recerca) ; Maestu, Inmaculada (Hospital Universitario Doctor Peset. Department of Medical Oncology) ; Ureste, Maria Martín (Hospital Universitario Doctor Peset. Department of Medical Oncology) ; Sanchez, Alfredo (Department of Medical Oncology, Consorci Hospitalari Provincial de Castelló, Castellón, Spain) ; Cordoba, Juan Felipe (Hospital Universitari Arnau de Vilanova. Department of Medical Oncology) ; Sansano, Irene (Hospital Universitari Vall d'Hebron) ; Venturas, Griselda (Hospital Universitari Vall d'Hebron) ; Ramón y Cajal, Santiago (VHIR Vall d'Hebron Institut de Recerca) ; Hernandez-Losa, Javier (VHIR Vall d'Hebron Institut de Recerca) ; Universitat Autònoma de Barcelona
Precision medicine has revolutionized the understanding and treatment of cancer by identifying subsets of patients who are amenable to specific treatments according to their molecular characteristics, as exemplified by epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). [...]
2019 - 10.1007/s40487-019-00099-9
Oncology and Therapy, Vol. 7 (august 2019) , p. 131-139  
2. / Sesé, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fuentes, Pedro (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Esteve-Codina, Anna (CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, Barcelona, Spain) ; Béjar, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; McGrail, Kimberley (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Thomas, George (Physiological Sciences Department, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain) ; Aasen, Trond (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Breast cancer is the most prevalent malignancy in women and there is an urgent need for new therapeutic drugs targeting aggressive and metastatic subtypes, such as hormone-refractory triple-negative breast cancer (TNBC). [...]
2017 - 10.18632/oncotarget.23145
Oncotarget, Vol. 8 (december 2017) , p. 114856-114876  
21 p, 5.1 MB
3.
6 p, 646.3 KB Internal translation of the connexin 43 transcript / Salat-Canela, Clàudia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sesé, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Peula, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Aasen, Trond (Molecular Hospital Universitari Vall d'Hebron. Institut de Recercan) ; Universitat Autònoma de Barcelona
Connexin 43 (Cx43), the most widely expressed gap junction protein, is associated with a number of physiological and pathological conditions. Many functions of Cx43 have been shown to be independent of gap junction formation and only require the expression of Cx43 C-terminal fragments. [...]
2014 - 10.1186/1478-811X-12-31
Cell Communication and Signaling : CCS, Vol. 12 (may 2014) , p. 31  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.